The post Ripple Backs $300 Million Korean Investment Fund in Partnership with VivoPower and Lean Ventures appeared on BitcoinEthereumNews.com. Ripple approves $The post Ripple Backs $300 Million Korean Investment Fund in Partnership with VivoPower and Lean Ventures appeared on BitcoinEthereumNews.com. Ripple approves $

Ripple Backs $300 Million Korean Investment Fund in Partnership with VivoPower and Lean Ventures

2025/12/14 11:34

Ripple approves $300M fund by VivoPower and Lean Ventures to expand equity access in South Korea amid growing institutional demand.

Ripple Labs has approved a $300 million investment fund to expand institutional access to its equity in South Korea. The fund, launched by VivoPower International in collaboration with Korean asset manager Lean Ventures, targets investors interested in Ripple and XRP-linked opportunities.

This move comes amid growing demand for structured crypto investment products in Asia and follows Ripple’s continued push into regulated financial markets.

Ripple Approves Investment Structure and Share Access

Ripple granted written consent for the initial tranche of preferred shares, enabling VivoPower and Lean Ventures to proceed with the fund. Vivo Federation, VivoPower’s digital asset division, will handle the sourcing and acquisition of Ripple Labs shares.

Lean Ventures, based in Seoul, will manage the fund and oversee investment operations. The firm already manages assets for both public and private Korean investors, giving the fund added credibility.

Ripple’s recent regulatory progress, including an OCC banking license in the U.S., has further increased institutional interest in Ripple-related products.

VivoPower and its partners are now negotiating with existing institutional shareholders to reach the $300 million fund target.

Strategic Focus on Korean Market Demand

According to VivoPower’s Advisory Council Chairman, Adam Traidman, the Korean market holds strategic value. He stated that Korean investors would be able to acquire Ripple equity at more favorable pricing compared to XRP’s current market valuation.

Lean Ventures’ Managing Partner Chris Kim confirmed that Korean institutions show continued interest in Ripple-related investment vehicles. He attributed this demand to ongoing developments in the Ripple network, including the XRP Ledger (XRPL) upgrade, which improves DeFi features and network stability.

Korean company K-Weather has also shown interest in joining the fund. VivoPower is conducting due diligence to acquire a 20% stake in K-Weather to further strengthen its presence in South Korea’s crypto investment landscape.

Related Reading: Mastercard Partners with Ripple, Gemini to Test RLUSD Stablecoin on XRPL

VivoPower Forecasts $75M in Revenue as Shares Gain

Following the fund announcement, VivoPower shares surged 13%, reaching $2.88, based on data from Yahoo Finance. The company estimates that it could earn $75 million in revenue over three years through management and performance fees linked to the fund’s operations.

Crypto analyst Crypto Eri noted that the structure of the fund could give investors exposure to Ripple equity and XRP at a potential discount to market prices.

She also emphasized that the fund’s three-year strategy aligns with Ripple’s ongoing network developments and increased institutional adoption, including recent RLUSD integrations.

Source: https://www.livebitcoinnews.com/ripple-backs-300-million-korean-investment-fund-in-partnership-with-vivopower-and-lean-ventures/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.